‘Adulting’ is hard. UC Berkeley has a class for that – Los Angeles Times

Conner Wright is carrying a demanding course load in his final year as an English major at UC Berkeley: antebellum American literature, introduction to music therapy and a research seminar on William Shakespeare.

The 20-year-old senior is immersed in the works of Henry David Thoreau, Ralph Waldo Emerson, Herman Melville and Harriet Jacobs.

But Wright, who is anticipating his graduation in May, has the self-awareness to know he needed a little something extra to prepare for his launch into a post-college world, that a superior ability to interpret classic literary works may not be enough.

So he signed up for a class on adulting, where he is learning to create and stick to a personal budget, build a resume and apply for jobs and navigate romantic relationships in a time when online interactions are eclipsing face-to-face encounters.

I need to learn how to get this adult thing down and manage life, Wright said.

The class, which has 30 students enrolled in each section, is led by two Berkeley undergrads who plan discussion topics and schedule guest speakers to fill 90 minutes each week. The adults in training are among thousands of people across the country who have signed up for courses that focus on things such as cooking or budgeting or time management.

Jenny Zhou, left, and Belle Lau teach an adulting class at UC Berkeley.

(Josh Edelson / For The Times)

Adulting classes for college students and postgrads have swelled in popularity in recent years, in part because many high schools have largely abandoned life skills courses such as home economics, which were created to help students navigate the path to adulthood.

That trend, combined with armies of hovering parents who emphasize academic achievement to the exclusion of almost everything else, has resulted in university classrooms filled with students who scored a 5 on their AP Physics test, but struggle to plan for a weeks worth of groceries and meals.

In Portland, Maine, the Adulting School offers in-person classes on soft skills, such as interviewing, conflict resolution and making friends, along with topics such as personal finance and basic home maintenance.

Principal Rachel Flehinger said her students, who are typically in their 20s and 30s, have experienced their share of disdain over their so-called entitlement and laziness.

Weve had clients who are millennials having major anxiety that they didnt have these skills and didnt feel successful as an adult, she said. Theres a lot of self-loathing that happens.

Similar classes or in-person workshops have popped up at libraries and universities across the country, in private groups on social media and even on blogs tailored to college students. Some high schools have scheduled seminars on life skills as a way to prepare their students for life after graduation.

Sometimes students come up with their own solutions.

Neither Belle Lau of Washington nor Jenny Zhou of Arizona felt fully prepared for life away from home when they arrived at Berkeley two years ago. When Lau moved out of the dorms and into her own apartment during her sophomore year, her lack of self-reliance at the time became apparent. She was working, attending classes and, for the first time, had to plan her own meals, put money aside and cover her expenses. She quickly realized that she was spending too much money eating out all the time.

More than 200 students at UC Berkeley applied for two adulting courses offered this semester. More than half of them had to be turned away because of limited class size.

(Josh Edelson / For The Times)

Lau and Zhou noticed that many of their peers were having similar struggles.

Were thrown out into this world and have little idea about what the heck were supposed to do, said Lau, 21. I think in general we all feel a little bit lost and dont know where to start.

To remedy that, Lau and Zhou, 20, decided to create their own class.

When it was first offered last spring, every one of the 30 spots was filled. Seventy students had to be turned away.

Lau and Zhou added a second session this semester. More than 200 students filled out applications explaining why they wanted to take the 12-week course. The women accepted fewer than half who applied.

Column One

A showcase for compelling storytelling from the Los Angeles Times.

Adulting is one of dozens of student-run courses in the universitys DeCal (Democratic Education at Cal) program, in which students create and facilitate their own classes on topics that include those practical and fun and often arent addressed in traditional curriculum. The project is rooted in the ideals of Berkeleys free speech movement, launched in the 1960s when students pressed for and won greater academic rights.

Theres a class on criminal psychology, which aims to analyze the minds of criminals, particularly of those who commit heinous crimes, in an effort to understand factors that influenced their behaviors and led them to commit violent offenses. Students enrolled in Intro to Baking learn to make bread, cakes, pastries and other confections without setting you or your roommates on fire, according to the course catalog.

Another course takes participants on a journey to Hogwarts School of Witchcraft and Wizardry through discussions of Harry Potter novels.

The courses in DeCal count for one or two credits and are offered as pass/no pass; as a result, students say they are unlikely to add to their stress levels.

College is a time of so many transitions the losing of certain reference points and its relatively sudden, said Nancy Liu, an assistant clinical professor of psychology at UC Berkeley and the faculty sponsor for the adulting class this semester. Youre on your own for the first time, youre navigating a large system with limited support, youre taken out of past comforts and starting anew, you have new tasks that youve never had to deal with before.

Add to that the stress of a high-pressure academic environment, it makes sense that many would feel overwhelmed, she said.

College also sets the tone for much of what comes afterward: fostering those daily habits and routines; balancing work, school and life; remembering to file your taxes and keeping a budget; learning how to navigate interpersonal challenges with less scaffolding or support from experienced others. It seems crucial to address it head-on in a way that was valuable to students, Liu said.

Students learn basic life skills that experts say have been abandoned by traditional academia.

(Josh Edelson / For The Times)

When Lau and Zhou decided to create a class, they initially envisioned a course in cooking, a passion they share. That idea morphed into life hacks and, later, adulting.

When the two began brainstorming a syllabus, daily tasks such as laundry, sewing and car maintenance didnt make the cut. Instead, they focused on topics that are more abstract: time management, budgeting, fitness and nutrition, and relationships.

Each 90-minute session features a presentation from Zhou and Lau, juniors majoring in molecular and cell biology and integrative biology, respectively, and an outside expert who visits the class in person or via video chat. Last year, a recruiter from Lyft prepped students about job searches and a former accountant discussed filing taxes.

Those accepted into the classes, mostly seniors, have lamented that many of the things they were learning werent taught by their parents.

Laus mother, Allie Wu, says that parents dont trust their kids enough to do things on their own, adding that when theyre at home their parents pretty much take care of everything for them.

Wu says she has always been very independent, a trait that was a necessity when she arrived in the United States from Taiwan as a 22-year-old to pursue her MBA. Wu hoped her daughter would leave home with the same sense of self-sufficiency. But when Lau confessed to her mother that she struggled a bit her first year at Berkeley, Wu said she began to worry.

Those concerns dissipated when Lau told her about the adulting class she wanted to start with a friend.

Wu, who visited the class last year to talk about taxes, said the course is wonderful and unique.

I know shes in a good place now. Im very proud of her, Wu said. She knows what she wants and what she needs to accomplish her goals.

UC Berkeley students Belle Lau, left, and Jenny Zhou teach an adulting class for their peers.

(Josh Edelson / For The Times)

During the first week of adulting at Berkeley this semester, students were asked to come up with goals that were SMART specific, measurable, attainable, relevant and time-based.

To kick it off, Zhou asked whether anyone had ever set a goal they didnt accomplish.

A few hands shot up. Several people shifted uncomfortably in their chairs. A handful looked around the room.

In less than a minute, everyones hand was in the air.

After a brief lecture, Lau and Zhou split the class into groups of six, each assigned to discuss their goals for the semester. Precision was rewarded; vagueness had to be remedied.

Students shuffled their desks into haphazard circles in the classroom and made quick introductions. They bantered about the dread of 8 a.m. classes and late-night studying marathons that would compound that trepidation as the semester dragged on.

Then things got uncomfortable.

Some of the students spoke in hushed tones as they shared the goals they had written on sheets of paper in front of them and, along with those, their insecurities that they might not be doing this whole grown-up thing quite right.

Wright spoke up first. His goal was to build more healthful habits with diet and exercise before graduation. The group nodded in agreement.

Several students said better time management would make a huge difference in their lives. One woman, a junior, said planning and establishing a routine might keep her from staying up all night cramming for exams.

Another piped up, saying shed like to get more done during the day by limiting how much time she spends on her phone a common distraction.

Kate Curtis, a 21-year-old senior who showed up 10 minutes late to the class with a look of embarrassment and a quick apology, said shes long struggled with punctuality. Shes been late so many times to her job at a fast-food restaurant that her manager recently pulled her into a meeting to discuss it. She was humiliated and ashamed.

I want to learn to be dependable. I want other people to be able to count on me, she said.

Curtis, who transferred to Berkeley from a community college in Orange County, said she lived at home for the first two years of college and feels she was coddled longer than her peers.

Im eight hours away from home now, so Im actually on my own. I have to find my own doctor if Im sick. Ive just signed up for my first loan, and Im not really understanding what Im getting into, she said.

Lau acknowledged that she and Zhou dont have all the answers, but shes quick to note that parents shouldnt be faulted for their childrens lack of real-world knowledge.

Maybe it is our parents who arent teaching us these things we thought we should already know, but we dont want to blame our parents for us being naive or ignorant, she said. Its our responsibility as college students to know that if were struggling in some aspect, there are resources out there for us.

Read the rest here:
'Adulting' is hard. UC Berkeley has a class for that - Los Angeles Times

Malaria-Transmitting Parasites Seem To Be Hampered By Minestrone And Other Soups : Goats and Soda – NPR

It could be that malaria-carrying parasites are rendered less potent by minestrone. hmproudlove/Getty Images hide caption

It could be that malaria-carrying parasites are rendered less potent by minestrone.

Bring in some soup.

The unusual homework assignment at London's Eden Primary School was for a science week project cooked up by parent Jake Baum. He's a professor of cell biology and infectious diseases at Imperial College London, and his lab's job is to find new ways to combat malaria, which kills half a million children each year.

Baum figured he could teach young students about the process of medical research through something both tasty and understandable: the go-to soup recipes their families use when someone gets sick.

"What makes a good medicine versus hocus-pocus?" explains Baum, who regularly preps his own favorite home remedy, something he calls "Jewish grandmother's chicken soup."

"It was not the plan to discover anything," he adds.

Sixty students transported their soup submissions to school in 15 milliliter plastic tubes. That's about 1 tablespoon. The soup was frozen, thawed (standard practice for samples) and then (much to the children's delight) centrifuged spun in a machine to separate different substances.

At the next step, filtration, four samples were determined to be too dense or oily to test. Although they were likely delicious, they didn't make it to the lab stage, where the remaining 56 samples were tested in two ways against the P. falciparum parasite the species responsible for 99% of malaria deaths.

First, researchers checked what effect the soups had on asexual growth during the disease-causing stage. Or, to put it in primary school terms, they were looking through the microscope for the color green.

"More green means [the parasites are] happy. With an inhibitor like a drug, it's less green," Baum says. They followed up by checking on male parasite sexual development, which is responsible for disease transmission. For that, they recorded the movement of the parasites because, as Baum notes, "sperm wiggle."

To Baum's surprise, with five of the soups, the color green was much dimmer five of them were able to suppress growth by over 50% (and two of these even did about as well as a leading antimalarial, dihydroartemisinin).

In other soups, there was a lot less wiggling. Four were found to have blocked transmission activity by more than 50%.

"We just said, 'Wow, what do we do with this?' " Baum says.

The answer turned out to be another teachable moment for the students, ages 4 to 11, who participated in the study. Although the results were collected within a few months, it took two years for the work to get published. Another Eden Primary parent, pediatric nephrologist Stephen Marks, helped pitch the study to journals and championed the idea that the children of the school should be listed as authors which they were when the study was finally released in November in the Archives of Disease in Childhood.

"Every kid can say they've had their first scientific paper," says Baum, who jokes that some may want to turn it into a paper airplane.

But it was a project they're likely to remember, notes Susanna Daniels, another parent/scientist, who also happens to be a soup enthusiast. As soon as her two children in the school came home to tell her about the experiment, there was some hypothesizing going on. "Our oldest was most disappointed because I'm a pescatarian. She was anxious our soup would fail because it wasn't chicken soup," explains Daniels, who opted to make her mother's veggie minestrone, loaded with cabbage, carrots, celery and tomato.

Turns out, that combo did especially well in the study, accounting for two of the samples that helped block transmission activity. "It wasn't a fluke finding because it was duplicated in both samples," Daniels says. The kids were thrilled to get the news, she adds. "They wanted to ring my mum straight away. She was quite bemused by the whole thing."

It's not so far-fetched to search for medical breakthroughs in your grandma's or great uncle's kitchen concoctions, Baum says, pointing to the scientific literature extolling the curative properties of chicken soup. (Research studies like this one suggest that it curbs some symptoms of upper respiratory tract infections.)

In terms of malaria treatment, the original lifesaving medicine was quinine, found in the bark of the South American cinchona tree. Today, the most commonly recommended anti-malaria drugs are derived from the artemesia plant (aka wormwood), which has been prescribed in traditional Chinese medicine for over 1,000 years. As Baum says, "Nature can produce fantastic molecules."

Pinpointing what exactly it was about these specific soups that had an effect would take years of additional research. For starters, it's hard to even tell what was in them. A bright red one probably contained beets, and a lot of them smelled like chicken. But students were never asked for a list of ingredients. Even though some kids had written information on the plastic tube samples they submitted, "when we wiped the tubes with ethanol, we lost the recipes," Baum says.

No one is claiming that these soups offer a promising pathway to a cure. "I'm using a lot of 'could, would, possibly,' " notes Baum, who doesn't have current plans for more soup experiments. But if he did and the resources were available he'd love to see it performed globally. Although the Eden Primary students come from diverse ethnic backgrounds, Baum says, they're all doing their grocery shopping in London. They can't pluck a leaf from a particular kind of bush the way kids in other parts of the world might.

Building on local knowledge is vital in malaria research, agrees Stephanie Yanow, a global health professor at the University of Alberta, who was not involved in the soup study. "We're at a difficult point every intervention we've tried, the parasite is always ahead of the game. Malaria numbers are going up in some places. There's drug resistance. The vaccine we have isn't very effective," she says. "We need to think outside the box and use more unconventional methods."

What struck her about the project was how well it engaged kids and their families and encourages "citizen scientists," or people without formal scientific training, to get involved in research.

And it's definitely made Yanow wonder what mysteries await in her minestrone. "There's a reason we think of it as a comfort food," she says.

Vicky Hallett is a freelance writer who regularly contributes to NPR.

Read the original:
Malaria-Transmitting Parasites Seem To Be Hampered By Minestrone And Other Soups : Goats and Soda - NPR

GE Healthcare Life Sciences pairs up with Advanced Solutions Life Sciences to create new opportunities for regenerative tissue manufacturing -…

MARLBOROUGH, Mass. & LOUISVILLE, Ky.--(BUSINESS WIRE)--GE Healthcare Life Sciences and Advanced Solutions Life Sciences (ASLS) will enter into a strategic R&D and distribution partnership that sets out to personalize tissue regeneration. The integration of IN Cell Analyzer and BioAssemblyBot systems technologies will embed cellular-level assessments into the 3D-bioprinting workflow used to create human tissue models.

Bioprinted tissues are small in size and die quickly, due to an inability to engineer small blood vessels the bodys supply network. ASLS patented Angiomics technology enables bioprinted microvessels to self-assemble into functional capillary beds, which deliver nutrients, oxygen, and hormones to the 3D tissue model and remove waste. This partnership would allow life scientists and tissue engineers to quickly design, build and image living, vascularized 3D tissues in a single, agile process.

Emmanuel Abate, General Manager of Genomics & Cellular Research, GE Healthcare Life Sciences, says: Printing multi-material 3D objects inside of microwell plates allows scientists to efficiently move away from traditional 2D monocultures on plastic, to 3D discovery and cytotoxicity models that more accurately reflect native biology and disease. By combining this flexibility and precision of the BioAssemblyBot with the image quality and speed of the IN Cell Analyzer 6500 HS confocal screening platform, the prospect of automating high content screening in 3D models can become a reality.

Currently, biopharmaceutical companies test their drugs in 2D models and animal models. Precise 3D models provide a more physiologically relevant environment for drug testing because they mimic human reactions.

The power of both of these platforms brings a new level of efficiency, speed and quality with assay designs and 3D biofabrication, says Michael Golway, President & CEO of ASLS.

Traditional 3D bioprinters are not designed for quality or interoperability with the high-throughput screening methods that pharmaceutical developers use to identify drug candidates. This alliance will result in a new product to address this challenge: an integration of GE Healthcare Life Sciences IN Cell Analyzer confocal imaging platform with IN Carta cell analysis software, and ASLS BioAssemblyBot 3D bioprinter with TSIM design software.

For pharmaceutical companies, where the average time to develop a new drug candidate may take over seven years, moving from traditional stage-gate testing processes to a lean, agile workcell for 3D tissue fabrication and assessments will shorten development timelines. The integration between IN Cell Analyzer and BioAssemblyBot enables the automated inclusion of cellular imaging information into the tissue modeling process so that new therapies can be scaled more quickly and effectively.

To learn more, please go to http://www.lifesciences.solutions/GE

For a live demonstration visit booth #908 at the joint meeting of the American Society of American Cell Biology (ASCB) and the European Molecular Biology Organization in Washington, DC taking place from December 7-11, 2019.

About GE Healthcare Life Sciences:

GE Healthcare Life Sciences helps therapy innovators, researchers and healthcare providers accelerate how precision diagnostics and therapies are invented, made and used. Our products enable biological analysis, research, development and the manufacture of advanced therapies and vaccines. Life Sciences is part of the $19.8 billion healthcare business of GE (NYSE: GE). With over 100 years of experience in the healthcare industry and more than 50,000 employees globally, GE Healthcare helps efficiently improve outcomes for patients, healthcare providers, researchers, and life sciences companies around the world. Visit our website https://www.gelifesciences.com/about-us for more information.

About Advanced Solutions Life Sciences:

Advanced Solutions Life Sciences (ASLS) is dedicated to the discovery, design, and development of integrated software and hardware solutions for the fields of science that involve living organisms, molecular biology, and biotechnology. ASLS offers a full-service business model including its patented, cGMP and UL certified BioAssemblyBot platform, as well as BioBot Basic, TSIM and BioApps Software, VIPM, and Professional Services. Visit http://www.bioassemblybot.com for more information.

See the original post here:
GE Healthcare Life Sciences pairs up with Advanced Solutions Life Sciences to create new opportunities for regenerative tissue manufacturing -...

Magenta Therapeutics Demonstrates First-ever Successful Gene Therapy Transplant Without Chemotherapy in Primates Using a Single Dose of Antibody-drug…

DetailsCategory: AntibodiesPublished on Monday, 09 December 2019 18:35Hits: 253

CAMBRIDGE, MA, USA I December 09, 2019 IMagenta Therapeutics (NASDAQ: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of immune reset to more patients, today announced that new results from its CD117-ADC patient preparation program were presented at the 61st Annual Meeting of the American Society of Hematology (ASH). These results, which were highlighted in an oral presentation at ASH by John Tisdale, M.D., Director, Molecular and Clinical Hematology Section, National Institutes of Health, showed the first-ever successful transplant of gene-modified cells in non-human primates using a targeted, single-agent antibody-drug conjugate (ADC), without the use of chemotherapy or radiation.

Todays conditioning regimens involve high doses of chemotherapy, often paired with radiation, to remove the disease-causing cells. As a result, patients undergoing gene therapy or stem cell transplant are all faced with a difficult choice: whether to endure severe toxicity and risk infertility and cancer for the chance for a cure. Magentas portfolio of targeted ADCs represents an extremely promising new option to prepare patients for gene therapy or transplant with no need for toxic chemotherapy or radiation, said Dr. Tisdale. The results presented today show that a single dose of single agent CD117-ADC achieves the same level of depletion as four doses of busulfan chemotherapy to enable successful engraftment and persistence of stem cells modified with the -globin gene, the gene that causes sickle cell disease and -thalassemia when mutated. Importantly, the animals undergoing preparation with CD117-ADC showed none of the damaging toxicities associated with busulfan conditioning.

Magenta is the only company with the people, platforms and a product engine committed to comprehensively transforming immune and blood system reset, which includes revolutionizing the toxic methods that are used to prepare patients for gene therapy and transplant today. said Jason Gardner, D.Phil., Chief Executive Officer and President, Magenta Therapeutics. The gene therapy field has learned that higher levels of stem cell depletion, which meant higher doses of busulfan, were needed to ensure long-term engraftment of the gene-modified cells and persistence of gene therapy. Across all the modalities we have tested, we have seen that ADCs are most effective at achieving these high levels of stem cell depletion without chemotherapy to enable engraftment and long-term durability of the transplant. Todays impressive results provide important validation of the ADC approach as well as the CD117 target for patient preparation and underscore Magentas leadership in the field of conditioning.

Results from the CD117-ADC Patient Preparation Program

Title: A Single Dose of CD117 Antibody Drug Conjugate Enables Autologous Gene-Modified Hematopoietic Stem Cell Transplant (Gene Therapy) in Nonhuman Primates (Abstract #610) Presenter: John Tisdale, M.D., Director, Molecular and Clinical Hematology Section, National Institutes of Health, Bethesda, Md.

Magentas most advanced patient preparation program, CD117-ADC, targets CD117, a protein expressed on hematopoietic stem cells. CD117-ADC is designed to remove the genetically mutated cells in the bone marrow that cause certain genetic diseases, such as sickle cell disease, enabling curative stem cell transplant or gene therapy.

Results presented by Dr. Tisdale showed:

About Magenta Therapeutics

Magenta Therapeutics is a clinical-stage biotechnology company developing medicines to bring the curative power of immune system reset through stem cell transplant to more patients with autoimmune diseases, genetic diseases and blood cancers. Magenta is combining leadership in stem cell biology and biotherapeutics development with clinical and regulatory expertise, a unique business model and broad networks in the stem cell transplant world to revolutionize immune reset for more patients.

Magenta is based in Cambridge, Mass. For more information, please visit http://www.magentatx.com.

SOURCE: Magenta Therapeutics

More:
Magenta Therapeutics Demonstrates First-ever Successful Gene Therapy Transplant Without Chemotherapy in Primates Using a Single Dose of Antibody-drug...

ERC promotes CRISPR research to better treat infections – News-Medical.net

Chase Beisel heads the "Synthetic Biology of RNA" research group at the Helmholtz Institute for RNA-based Infection Research (HIRI) in Wrzburg, a branch of the Helmholtz Centre for Infection Research (HZI) in Braunschweig and run in collaboration with the Julius-Maximilians-Universitt in Wrzburg. With the Consolidator Grants, the European Research Council (ERC) promotes research by up-and-coming scientists in Europe.

CRISPR is a word on everyone's lips at the moment. Although it sounds somewhat crispy and delicious, it is in fact inedible - it is actually one of the most promising tools of genetic engineering. CRISPR stands for "Clustered Regularly Interspaced Short Palindromic Repeats". These short DNA segments in the genome of bacteria are named after their regular pattern of repeating and mirrored sequences. They act as effective virus defence systems for bacteria. Copies of the CRISPR DNA exist in the form of RNA fragments in the cell. In the event of a viral attack, where a virus injects its DNA into a bacterium, the defence mechanism is triggered: The proteins, which include Cas9, is called to action and compares the sequence of the foreign DNA with that of the CRISPR RNA fragments. If it finds a matching counterpart, Cas9 cuts the foreign virus DNA, thus rendering the intruder harmless. The CRISPR-Cas9 system is therefore also known as genetic scissors and is now used for genome editing. DNA sequences can be specifically cut and modified in the laboratory using custom-designed CRISPR gene scissors, for example for the development of improved crops or medicines, for the manufacture of industrially used microorganisms, and in human cells for treating genetic diseases.

American chemical engineer Chase Beisel dedicated himself to CRISPR research around nine years ago. "We have an incredibly powerful genetic engineering tool at our disposal," says Beisel. "In order to fully and safely utilise its potential in the future, it is important that we better understand the basic biological relationships of CRISPR complexes in bacteria." The bacterial immune system can evidently learn new things and arm itself against other attackers by quickly integrating parts of foreign DNA into its own genome. CRISPR arrays encode the memory of previous infections and enable multiple intruders to be attacked simultaneously. How exactly these advanced CRISPR complexes are created, which criteria are used for selecting new sequences and which key genes of the attacker are thus rendered ineffective are not yet fully understood. This is exactly where Beisel's current research project "CRISPR Combo" aims to start, addressing the unanswered questions. "In addition to researching the biological fundamentals of CRISPR arrays in bacteria, we would also go one step further in the direction of a genetic application of CRISPR arrays," says Beisel. "To do this, we will use designed CRISPR arrays to target multiple genes at once in pathogens, thereby identifying combinations that most drive infections and providing new drug targets."

In 2018, Beisel moved from the Department of Chemical and Biomolecular Engineering at the North Carolina State University in Raleigh (USA) to the HIRI in Wrzburg, where he has been the head of the "RNA Synthetic Biology" research group for two years now. His twelve-person team consists of postdocs, doctoral candidates, technicians and students. "The funding from the ERC means I can confidently add four members to the team - that is really fantastic," says Beisel. "The ERC Grant is an important milestone for me personally. Making the leap to Germany to join the HIRI was absolutely the right decision, and I am delighted about this funding. It enables me to dedicate my research to a topic that fascinates me and at the same time offers significant benefits for society as a whole."

Posted in: Medical Science News | Medical Research News | Disease/Infection News

Tags: Bacteria, Cas9, Cell, CRISPR, DNA, Gene, Genes, Genetic, Genetic Engineering, Genome, Genome Editing, Hospital, Immune System, Laboratory, Palindromic Repeats, Research, Research Project, RNA, Virus

Continued here:
ERC promotes CRISPR research to better treat infections - News-Medical.net

Biochemistry Analyzers Market: A Latest Research Report to Share Biochemistry Analyzers Industry Insights and Dynamics By 2026 – Market Strategies

The research report on the global Biochemistry Analyzers marketprovides a comprehensive outlook of the equipment and technological devices employed in the manufacturing of the Biochemistry Analyzers market products. From industry chain analysis to cost structure analysis, the report examines various factors of the industry, including production and end-use segments of the Biochemistry Analyzers market. The current trends in the pharmaceutical industry have been highlighted in the report to evaluate their influence on the overall output of the Biochemistry Analyzers market. The Biochemistry Analyzers Market analyzed in this study is speculated to grow at a CAGR of XX% during the forecast period (2019-2026).

Fill in your details to get your hands on an Exclusive Sample of this Report @ https://www.marketexpertz.com/sample-enquiry-form/71860

Competitive Landscape:

The Biochemistry Analyzers market is moderately competitive and includes numerous key players. When looking at market share, few industry players predominantly constitute the worldwide market. With the growing awareness among patients and high prevalence of diseases like cancer, new companies are also expected to find their way into the market in the near future.

Some of the major players engaged in the market are :

Roche Diagnostics GmbH, Siemens AG, Beckman Coulter Inc., Abbott Diagnostics Inc., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Hologic, Inc., Randox Laboratories Ltd., Awareness Technology, Inc., Transasia Biomedicals Ltd, Nova Biomedical Corp.

Results of the latest scientific undertakings for the development of new Biochemistry Analyzers products have also been considered. Factors that can potentially influence the leading industry players to implement synthetic sourcing of market products have also been studied in this investigative report. The inferences drawn in this study are valuable for any company operating in the industry. Every organization contributing to the global production of the Biochemistry Analyzers market products has been profiled in this report, in order to study the insights on cost-effective manufacturing methods, competitive landscape, and new avenues for applications.

Biochemistry Analyzers Market Segmentation:

Type of Biochemistry Analyzers Market:

Semi-automated Biochemistry Analyzer, Fully Automated Biochemistry Analyzer

Application of Biochemistry Analyzers Market:

Clinical Diagnostics, Bioreactor Byproduct Detection, Drug Development Applications, Others

Grab Your Report at an Impressive Discount! Please Click Here @ https://www.marketexpertz.com/discount-enquiry-form/71860

The varying scenarios across the global market have been examined in this study, providing an overview of how the Biochemistry Analyzers products have established their place in this rapidly-evolving sector. Industry participants will be able to formulate their strategies and tactics by assessing the speculated market size for the forecast mentioned in the report. Favorable regional markets for the Biochemistry Analyzers have been described, which are expected to impact the global expansion strategies of the leading organizations. Additionally, key manufacturers have been profiled comprehensively in this research report.

In market segmentation by geographical regions, the report has analyzed the following regions-

North America

Europe

China

Japan

Middle East & Africa

India

South America

Others

With the existing market standards evaluated, this research report also explains the latest strategic initiatives and patterns of the market players in an unbiased way. The report can be construed as a presumptive business record that can aid the readers functioning in the global market devise their plans effectively, to reach the desired position in the market in the forecast period.

Read the Comprehensive Report with a meticulous TOC and panoramic coverage of the [emailprotected] https://www.marketexpertz.com/industry-overview/biochemistry-analyzers-market

Report Methodology:

The data contained in this report has been derived through both primary and secondary research methodologies.

Primary research methodology includes interaction with service providers, suppliers, and industry professionals. Secondary research methodology entails a thorough examination of relevant literature like company annual reports, financial reports, and exclusive databases.

This report provides:

Request customized copy of Biochemistry Analyzers report

We are grateful to you for reading our report. If you wish to find more details of the report or want a customization, contact us. You can get a detailed information of the entire research here. If you have any special requirements, please let us know and we will offer you the report as you want.

Need to customized? Ask Our Expert @ https://www.marketexpertz.com/customization-form/71860

Continued here:
Biochemistry Analyzers Market: A Latest Research Report to Share Biochemistry Analyzers Industry Insights and Dynamics By 2026 - Market Strategies

Biochemistry Analyzers Market to Receive Overwhelming Hike in Revenues by 2026 – Montana Ledger

GlobalBiochemistry Analyzers Market: Overview

The report details an exhaustive account of the global biochemistry analyzers market along with numerous associated factors. Some of these factors that are included in the report are drivers, restraints, competitive analysis, latest trends and opportunities, geographical outlook, and many other aspects. The study covered in the report spans a forecast period from 2018 to 2028. From an overall perspective, the report is expected to exist as a valuable insight to businesses which are already operating in the global biochemistry analyzers market, as well for those who intend to newly establish themselves in this environment.

GlobalBiochemistry Analyzers Market: Market Potential and Restraints

Widespread advancements in the medical field have primarily been responsible for driving the global biochemistry analyzers market. Moreover, with rising geriatric population, the numbers of health issues are gradually increasing, thereby increasing demand for relevant treatments that involve biochemical analyzers. In addition, these analyzers possess a high rate of identification of a specific pathogen, consequently providing high clarity and accuracy.

Request Brochure of Biochemistry Analyzers Market Report

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=50526

These characteristics make the use of the biochemical analyzers more suitable than other alternatives, thereby boosting growth in the global biochemical analyzers market. Technological advancements are expected to increase even more in the near future, consequently projected to further stoke expansion in the global biochemical analyzer market. Increasing use of the analyzers in drug monitoring, drug abuse detection, and drug provision, owing to rise in the number of health conditions too is notably contributing towards growth witnessed by the global biochemistry analyzers market.

However, this market is hindered owing to several factors. A prominent obstacle present in its growth involves lack of expertise and shortage of necessary manpower required to provide the treatments that involves use of biochemistry analyzers in remote and underdeveloped regions. Owing to this, the market remains restrained geographically. Moreover, high costs of manufacturing the analyzer compounds might cause difficulties for small-scale healthcare centers to afford the required equipment.

In addition, there are several complexities involved with carrying out medical processes that make use of the analyzers. Due to this, people might prefer traditional and cheaper alternatives, which is notably hampering progress in the global biochemistry analyzers market. Nonetheless, key players are soon expected to introduce cost-effective analyzer production procedures, thus blanketing most restraints affecting the global biochemistry analyzers market.

Request for a Discount on Biochemistry Analyzers Market Report

https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=50526

GlobalBiochemistry Analyzers Market: Geographical Outlook

This market is mainly spread across North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America. Of these, a strong medical infrastructure in North America has made this region hold a leading stance with maximum market share. Many organizations are growing in the global biochemistry analyzers market in North America owing to the availability of necessary funds, mainly to conduct research and develop new and efficient treatments. However, apart from North America, Asia Pacific too showcases a splendid growth present in the global biochemistry analyzers market. This is majorly due to the introduction and utilization of various treatment procedures wherein biochemistry analyzers play a huge role. In addition, several companies are pouring extensive investments in developed economies located in Asia Pacific, which is anticipated to strengthen the market in this region.

GlobalBiochemistry Analyzers Market: Competitive Landscape

This market depicts the presence of a substantially competitive vendor landscape, with the presence of a handful of players exerting their respective dominance. Regulation of treatment costs, achieving geographical expansion, and bringing forth medical treatment efficiency are key strategies implemented by most players operating in the global biochemistry analyzers market. Abbott Diagnostics Inc., Hologic, Inc., Transasia Biomedicals Ltd., Beckman Coulter Inc., Roche Diagnostics GmbH, Siemens AG, Randox Laboratories Ltd., Awareness Technology, Inc., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., and Nova Biomedical Corp., are chief players operating in this sector.

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

ContactTransparency Market ResearchState Tower,90 State Street,Suite 700,Albany NY 12207United StatesTel:+1-518-618-1030USA Canada Toll Free:866-552-3453Email:[emailprotected]Website:http://www.transparencymarketresearch.com

Read the original:
Biochemistry Analyzers Market to Receive Overwhelming Hike in Revenues by 2026 - Montana Ledger

Researcher who uncovered the sex life of marsupials awarded Academy’s most prestigious medal – Australian Academy of Science

December 09, 2019

A scientist whose research has transformed our understanding of Australias iconic mammals has been recognised by the Australian Academy of Science. Professor Marilyn Renfree AO FAA has been awarded the Academys highest honour in the biological sciencesthe Macfarlane Burnet Medal and Lecture.

For half a century the committed reproductive and developmental biologist and conservationist from the University of Melbourne has been using the tammar wallaby, a small macropodid marsupial native to South and Western Australia, to study their reproduction and development.

Professor Renfree has developed contraceptive strategies for kangaroos and koalas and established marsupials as unique biomedical models for understanding human reproduction.

She is now a world authority on marsupial reproduction and development and has pioneered research on some of Australias most iconic creatures including kangaroos, koalas and now echidnas.

And with passion for her work as strong as ever, she has no plans of slowing down. Professor Renfree has just embarked on the worlds first study of the development of the embryo and newly hatched pouch young from the echidna.

Professor Renfree said hardly anything was known about marsupials when she started out.

Im passionately Australian and I really wanted to work on something Australian but when I started honours I said to my prospective supervisors: I wanted to do biochemistry and fieldwork. And they laughed at me. Well, Im still really doing biochemistry and fieldwork.

Her first paper published from her PhD in 1972 was aNaturepublication.

In her distinguished career Professor Renfree has made numerous research breakthroughs. In research with colleagues Professor Renfree conducted the first genome sequencing of an Australian marsupial, the tammar wallaby, providing new information on their evolution.

She also showed that certain genes directly control sexual development during pregnancy and even after birth in marsupials, providing a new understanding of the relative influence of genes versus hormones in sexual differentiation in all mammals. With colleagues she also discovered a new hormone pathway that explains some human disorders of sexual development.

Professor Renfree said Australia is sitting on a biological goldmine because it is home to a unique assembly of mammalsthe marsupials and monotremes.

The impact of Australias recent bushfires on Australian mammals has highlighted Australia and the worlds fascination with these special animals. We really need to put more effort, time and money into conserving and doing research on them, Professor Renfree said.

Australia has the distinction of having the worst record of mammal extinctions of any developed country and thats not a record you want to be proud of.

Professor Renfree said the Academy award is a huge honour.

Im receiving it on behalf of all of my students, PhD students and postdocs and collaborators. Without them I could have only done a fraction of what I've done, Professor Renfree said.

She was nominated for the medal by Professor James Angus FAA from the University of Melbourne.

Professor Renfree is a pioneer and forward thinker who has an ability to excite and inspire scientists from around the world by providing new insights through the study of the unique evolutionary innovations in the reproductive systems of marsupials and monotremes, Professor Angus said.

The basic science and the clinical impact of her work for humans are as important as the direct benefits of her work for Australias marsupials. Her research has undoubtedly opened the eyes of the academic world and beyond to the value of these iconic Australian mammals both for their intrinsic interest and as unique biomedical models.

Professor Renfree will receive the medal and give a lecture at the Academys Science at the Shine Dome event in May 2020. The Macfarlane Burnet Medal and Lecture honours the contributions to science by Sir MacFarlane BurnetOMKBMDFAAFRSNobel Laureate.

See the original post here:
Researcher who uncovered the sex life of marsupials awarded Academy's most prestigious medal - Australian Academy of Science

Introducing the Autophagy and Proteostasis Collection – PLoS Blogs

The importance of proteostasis is becoming increasingly apparent as disrupted proteostasis and dysregulation of proteostasis-associated networks has been linked with aging and many age-associated diseases such as Alzheimers, Parkinsons and Huntingtons disorders. In recognition of the importance of this subject, PLOS ONE, alongside PLOS Biology, launched a Call for Papers on the topic of Autophagy and Proteostasis earlier this year. We welcomed a range of submissions that provided insight into the molecular and cellular machinery, and mechanisms that regulate autophagy and the crosstalk of this process with other protein quality control pathways to ensure proteostasis. These studies also underline the importance of all these cellular pathways in pathophysiological conditions and aging. The Guest Editors are Sharon Tooze (Francis Crick Institute, United Kingdom), Fulvio Reggiori (University Medical Centre Groningen, The Netherlands) and Thorsten Hoppe (Institute for Genetics and CECAD Center for Aging Research, University of Cologne, Germany).

We are happy to launch this Collection today, which includes five studies published in PLOS ONE that highlight the relevance of autophagy and other pathways such as the ubiquitin proteasome-system in maintaining protein homeostasis. In human cells, Ferreira et al. showed that when the STUB1/CHIP ubiquitin ligase is inactivated, cells increase secretion of extracellular vesicles (EVs) enriched in ubiquitylated or stabilized proteins, suggesting that cells use these EVs to dispose of proteotoxic material. Studying another E3 ubiquitin ligase, Si and colleagues investigate the mechanism for Pink1- and Parkin-mediated mitophagy in indirect flight muscles in Drosophila melanogaster, and showed that Pink1/Parkin are crucial for muscle function in aged muscles in an Atg1-dependent manner. Autophagy also plays crucial roles in the fungus Aspergillus niger and Kaur and Punekar revealed that acidogenic growth appears to mimic a nutrient deficient condition, and acidogenic growth and metabolism are compromised in atg1 and atg8 strains of A. niger.

In addition, two papers in the Collection showcase research investigating proteostasis dysfunction in disease states, and potential ways to modulate autophagy for therapeutic uses. Aviazidis et al. study proteostasis network dysfunction caused by unbalanced karyotypes using human Downs syndrome fibroblasts, showing that decreased abundance of SNARE family members STX17 and VAMP8 maybe responsible for reducing autophagic flux by impairing autophagosome-lysosome fusion. Bhaskar et al. identify lipoarabinomannan (LAM), a crucial lipid component of the Mycobacterium indicius pranii cell-wall, as an inducer of autophagy that leads to the enhancement of co-localization between Mycobacteriaum tuberculosis and phago-lysosomes, and increased clearance of this bacterium in macrophages.

Papers will continue to be added to the Collection as they are published. Stay tuned for new articles and additional insights on this important topic.

Fulvio Reggiori

Fulvio Reggiori is a Professor and Section Head of Molecular Cell Biology at the Department of Biomedical Sciences of Cells and Systems of the University Medical Centre Groningen, The Netherlands. Fulvio obtained in his PhD in Biochemistry from the University of Fribourg, Switzerland, in the laboratory of Professor Andreas Conzelmann. Subsequently, he moved to the MRC Laboratory in Molecular Biology in Cambridge to join the laboratory of Dr. Hugh Pelham, UK in 1998. In 2001, Fulvio moved to the University of Michigan in Ann Arbor, USA to the laboratory of Professor Daniel Klionsky, where he started working on different aspects of the molecular mechanisms of autophagy in yeast. In 2005 he was appointed as an Assistant Professor at the Department of Cell Biology of the University Medical Center Utrecht, The Netherlands before becoming an Associate Professor in 2011. Fulvio moved his lab in 2015, to the Department of Department of Biomedical Sciences of Cells and Systems of the University Medical Center Groningen where he became Professor. His research continues to investigate the molecular mechanisms of autophagy using Saccharomyces cerevisiae as a model organism as well as understanding the interaction between autophagy and pathogens, in particular viruses.

Sharon Tooze

Sharon Tooze is a Senior Group Leader at the Francis Crick Institute, London, UK. She has a long-standing interest in understanding organelle biogenesis using molecular cell biology approaches. Sharon received her PhD and undertook a postdoctoral research position in Wieland Huttners lab at the European Molecular Biology Laboratory (EMBL). She established a lab at Imperial Cancer Research Fund, UK which later became known as the Cancer Research UK London Research Institute. In 2015 she moved her lab to the Francis Crick Institute where her research continues to focus on autophagy. Her current interests are focused on expanding our knowledge of the core autophagy proteins in mammalian cells at the molecular level, in particular the autophagy proteins which initiate the formation of the autophagosome.

Thorsten Hoppe

Thorsten Hoppe is a Professor at the Institute for Genetics and the Center for Aging Research (CECAD) at the University of Cologne, Germany. He received his PhD from the University of Heidelberg working in the lab of Stefan Jentsch at the Center for Molecular Biology in Heidelberg (ZMBH) and the Max Planck Institute of Biochemistry in Martinsried. He undertook is postdoctoral work in the Department of Molecular Neurogenetics in the group of Ralf Baumeister at the LM-University of Munich before setting up his own group in 2003 at the Centre for Molecular Neurobiologie at the University of Hamburg (ZMNH). In 2008 he moved his lab to the Institute for Genetics and was Acting Director from 2011 to 2013. His research focuses on understanding the role proteostasis plays in aging and age-associated diseases.

Go here to see the original:
Introducing the Autophagy and Proteostasis Collection - PLoS Blogs

Koeppe Recognized for Service as ABI Institutional Director at University of Arkansas – University of Arkansas Newswire

Chieko Hara, University Relations

From left, Dan Sui, vice chancellor for research and innovation; Roger Koeppe, Distinguished Professor of chemistry and biochemistry; and Robert "Bobby" McGehee, executive director of Arkansas Biosciences Institute and dean at UAMS Graduate School

Science and engineering researchers at the University of Arkansas use research awards from the Arkansas Biosciences Institute to improve the health of Arkansans and prevent smoking-related illnesses.

Seed funding from the institute, a statewide consortium consisting of five research institutions, often enables researchers to produce preliminary results that help them and the university compete for large grants from federal agencies, such as the National Science Foundation and the National Institutes of Health.

As the U of A's institutional director and ABI representative for 11 years, Roger Koeppe, Distinguished Professor in the Department of Chemistry and Biochemistry, helped many colleagues secure funding from the institute. Koeppe was recognized for his service Thursday during a faculty town hall meeting to discuss future funding priorities and strategies of the Arkansas Biosciences Institute. The meeting was hosted by Dan Sui, vice chancellor for research and innovation.

"ABI funds have made a huge difference on this campus, certainly in terms of biosciences research, but also as leverage to attract and recruit top investigators," Sui said. "Obviously, Roger has been responsible so much its success on this campus, and we want to recognize his enormous contribution."

Earlier this semester, Chancellor Joe Steinmetz appointed Sui to serve as the new ABI institutional director.

The Arkansas Biosciences Institute was established as a result of Arkansas' share of the 1998 nationwide tobacco settlement. Health care leaders in the state sought a productive way to disperse the state's share of the settlement. TheArkansas Biosciences Institutewas created as a conduit for research that could help reduce or prevent smoking-related illnesses.

Arkansas voters endorsed the proposed Tobacco Settlement Proceeds Act of 2000, and the Arkansas Legislature enacted the provisions of that proposal as Acts 1569 through 1580 of 2001. Part of that legislation established the institute as a consortium of five research institutions: the University of Arkansas, the University of Arkansas System Division of Agriculture, the University of Arkansas for Medical Sciences, Arkansas State University and Arkansas Children's Hospital. Since ABI's beginning, scientists at these institutions have focused on biomedical and agricultural research with medical implications.

Robert "Bobby" McGehee, executive director of the Arkansas Biosciences Instituteand dean at University of Arkansas for Medical Sciences Graduate School, also recognized Koeppe during Thursday's meeting. He and Koeppe served together for more than a decade.

McGehee said Arkansas is one of only two states that uses all of its tobacco settlement money for heath inititatives and healthcare research. Sui said the university will continue to use ABI funds to make new strategetic investments in biosciences research.

Link:
Koeppe Recognized for Service as ABI Institutional Director at University of Arkansas - University of Arkansas Newswire